Lenvatinib: tested in a combination
307 studies: another drug in the study is under test too. Page 4 of 4. Open to participants first (149), then studies with results posted, then the rest; newest registration first within each.
- Neoadjuvant Treatment Associated With Maintenance Therapy by Anti-PD1 Immunotherapy in Patients With Resectable Head and Neck Mucosal MelanomaActive, not recruitingNCT03313206Phase 2Report a problem
- Capecitabine and Lenvatinib With External Radiation in Rectal AdenocarcinomaCompletedNCT02935309Phase 1Report a problem
- Lenvatinib and Capecitabine in Patients With Advanced MalignanciesWithdrawnNCT02915172Phase 1Report a problem
- Study of Pembrolizumab (MK-3475) Combination Therapies in Metastatic Castration-Resistant Prostate Cancer (MK-3475-365/KEYNOTE-365)Active, not recruitingNCT02861573Phase 1/2Report a problem
- Lenvatinib and Weekly Paclitaxel for Patients With Recurrent Endometrial or Ovarian CancerCompletedNCT02788708Phase 1Report a problem
- Effect of Cabozantinib S-Malate or Lenvatinib Mesylate on Weight and Body Composition in Patients With Metastatic Endocrine CancerCompletedNCT02592356Not applicableReport a problem
- Neoadjuvant Lenvatinib Combined With Letrozole in Hormone Receptor Positive Breast CancerActive, not recruitingNCT02562118Phase 1/2Report a problem